TMEM163

Chr 2AD

transmembrane protein 163

Also known as: DC29, HLD25, SLC30A11, SV31

Predicted to enable zinc ion binding activity. Involved in intracellular zinc ion homeostasis; myelination; and zinc export across plasma membrane. Is active in late endosome; lysosome; and plasma membrane. Implicated in hypomyelinating leukodystrophy 25. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

Leukodystrophy, hypomyelinating, 25MIM #620243
AD

Clinical highlights

0
Active trials
13
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.85
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.85LOEUF
pLI 0.040
Z-score 1.91
OE 0.37 (0.18–0.85)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.77Z-score
OE missense 0.59 (0.49–0.70)
85 obs / 144.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.37 (0.18–0.85)
0≤0.351.4
Missense OE?0.59 (0.49–0.70)
0≤0.61.4
Synonymous OE?1.00
0≤1.21.6
LoF obs/exp: 4 / 10.8Missense obs/exp: 85 / 144.8Syn Z: -0.00

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TMEM163 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →